Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DRF 4367

Known as: DRF-4367, DRF4367 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
SummaryDRF-4367 is a novel COX-2 inhibitor, which showed good efficacy in several animal models of inflammation. In a comparative… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
SummaryThe pharmacokinetic characterization of DRF-4367 (a new diaryl pyrazole derivative), a potent selective COX-2 inhibitor… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3
Is this relevant?
2006
2006
The purpose of the present study was to investigate the influence of a polyhydroxy base, N-acetyl glucamine (also know as… Expand
Is this relevant?
2005
2005
A simple, precise and accurate isocratic reverse-phase liquid chromatography method with programmed wavelength detection has been… Expand
Is this relevant?
2005
2005
The aim of this study was to characterize the pharmacokinetics and determine the absolute bioavailability and metabolism of DRF… Expand
Is this relevant?
2004
2004
Analogs of 1,5-diarylpyrazoles with a novel pharmacophore at N1 were designed, synthesized and evaluated for the in-vitro… Expand
Is this relevant?
2004
2004
A specific, accurate, precise and reproducible high-performance liquid chromatography (HPLC) method was developed for the… Expand
Is this relevant?